Brokerages Set Teladoc Health, Inc. (NYSE:TDOC) Target Price at $11.26

Shares of Teladoc Health, Inc. (NYSE:TDOC) have been given a consensus recommendation of “Hold” by the eighteen brokerages that are currently covering the stock, MarketBeat reports. Eleven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $11.26.

A number of research analysts recently commented on the company. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a research report on Thursday, February 27th. Royal Bank of Canada boosted their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Bank of America increased their price target on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research report on Wednesday, February 12th. The Goldman Sachs Group cut their target price on Teladoc Health from $16.00 to $13.00 and set a “buy” rating for the company in a research note on Monday, March 3rd. Finally, Piper Sandler reduced their target price on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a report on Thursday, February 27th.

Insider Buying and Selling

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the sale, the insider now owns 64,308 shares of the company’s stock, valued at approximately $541,473.36. This represents a 14.62 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.95% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Teladoc Health

A number of institutional investors have recently modified their holdings of the company. Point72 Asset Management L.P. grew its stake in Teladoc Health by 57.8% during the third quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider’s stock worth $76,803,000 after purchasing an additional 3,063,172 shares during the period. Maple Rock Capital Partners Inc. increased its stake in shares of Teladoc Health by 189.5% in the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider’s stock valued at $32,369,000 after acquiring an additional 2,331,000 shares in the last quarter. Two Sigma Investments LP acquired a new position in shares of Teladoc Health during the 4th quarter valued at $18,348,000. Two Sigma Advisers LP boosted its stake in Teladoc Health by 213.0% during the fourth quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider’s stock worth $20,532,000 after acquiring an additional 1,537,094 shares in the last quarter. Finally, Vanguard Group Inc. increased its stake in Teladoc Health by 5.9% in the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider’s stock valued at $167,830,000 after purchasing an additional 1,029,829 shares in the last quarter. 76.82% of the stock is owned by institutional investors.

Teladoc Health Price Performance

Shares of Teladoc Health stock opened at $8.86 on Tuesday. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $1.54 billion, a price-to-earnings ratio of -1.53 and a beta of 1.27. Teladoc Health has a twelve month low of $6.76 and a twelve month high of $15.43. The company has a 50-day simple moving average of $10.40 and a two-hundred day simple moving average of $9.77.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The company had revenue of $640.49 million during the quarter, compared to the consensus estimate of $639.44 million. Analysts forecast that Teladoc Health will post -1.16 EPS for the current year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.